Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Insights into therapeutic products, preclinical research models, and clinical trials in cardiac regenerative and reparative medicine: where are we now and the way ahead. Current opinion paper of the ESC Working Group on Cardiovascular Regenerative and Reparative Medicine

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Genome-wide association studies of cardiac electrical phenotypes

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Genome-wide association study identifies locus at chromosome 2q32.1 associated with syncope and collapse

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Genetic associations and regulation of expression indicate an independent role for 14q32 snoRNAs in Human Cardiovascular Disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Proteoglycan Remodeling Is Accelerated in Females with Angina Pectoris and Diffuse Myocardial Fibrosis: the iPOWER Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Diagnostic performance of a new ECG algorithm for reducing false positive cases in patients suspected acute coronary syndrome

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Reparative cell therapy for the heart: critical internal appraisal of the field in response to recent controversies

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Lilian Grigorian-Shamagian
  • Ricardo Sanz-Ruiz
  • Andreu Climent
  • Lina Badimon
  • Lucio Barile
  • Roberto Bolli
  • Steven Chamuleau
  • Diederick E Grobbee
  • Stefan Janssens
  • Jens Kastrup
  • Leyla Kragten-Tabatabaie
  • Rosalinda Madonna
  • Anthony Mathur
  • Philippe Menasché
  • Giulio Pompilio
  • Felipe Prosper
  • Emily Sena
  • Nicola Smart
  • Wolfgram-Hubertus Zimmermann
  • Francisco Fernández-Avilés
View graph of relations

Great expectations have been set around the clinical potential of regenerative and reparative medicine in the treatment of cardiovascular diseases [i.e. in particular, heart failure (HF)]. Initial excitement, spurred by encouraging preclinical data, resulted in a rapid translation into clinical research. The sobering outcome of the resulting clinical trials suggests that preclinical testing may have been insufficient to predict clinical outcome. A number of barriers for clinical translation include the inherent variability of the biological products and difficulties to develop potency and quality assays, insufficient rigour of the preclinical research and reproducibility of the results, manufacturing challenges, and scientific irregularities reported in the last years. The failure to achieve clinical success led to an increased scrutiny and scepticism as to the clinical readiness of stem cells and gene therapy products among clinicians, industry stakeholders, and funding bodies. The present impasse has attracted the attention of some of the most active research groups in the field, which were then summoned to analyse the position of the field and tasked to develop a strategy, to re-visit the undoubtedly promising future of cardiovascular regenerative and reparative medicine, based on lessons learned over the past two decades. During the scientific retreat of the ESC Working Group on Cardiovascular Regenerative and Reparative Medicine (CARE) in November 2018, the most relevant and timely research aspects in regenerative and/or reparative medicine were presented and critically discussed, with the aim to lay out a strategy for the future development of the field. We report herein the main ideas and conclusions of that meeting.

Original languageEnglish
JournalCardiovascular Research
Volume117
Issue number6
Pages (from-to)1428-1433
Number of pages6
ISSN0008-6363
DOIs
Publication statusPublished - 25 May 2021

Bibliographical note

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

ID: 68396856